RxDoctor Payments Data

Cynthia Sumner, MD

Internal Medicine · Fort Gaines, GANPI 1235181884

Payments from drug & device makers

$1,854in general payments, 2019–2025

Across 117 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$402
  • Novo Nordisk$364
  • AbbVie$197
  • Astellas Pharma US Inc$177
  • Pfizer$108
  • Johnson & Johnson$103
  • plus $504 from 18 others

What the payments were for

  • Food & beverage$1,854100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,854 in reported general payments places this provider in the 75th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$54,856
Medicare patients
230
Services billed
1,054

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate111$106,344
MounjaroTirzepatide88$94,847
EliquisApixaban100$82,306
OzempicSemaglutide45$60,769
XareltoRivaroxaban54$48,791
MyrbetriqMirabegron68$39,441
JardianceEmpagliflozin26$26,512
Tresiba Flextouch U-100Insulin Degludec34$24,958
RybelsusSemaglutide14$24,214
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$17,577
Breo ElliptaFluticasone/Vilanterol35$17,205
NexiumEsomeprazole Magnesium21$15,040
VascepaIcosapent Ethyl32$14,878
TrulicityDulaglutide11$14,329
Lantus SolostarInsulin Glargine,hum.Rec.Anlog90$13,871

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$13$109,17699 claims
MerckJanuvia$37$106,344111 claims
Novo NordiskOzempic, Rybelsus$364$84,98259 claims
PfizerEliquis$108$82,306100 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arexvy$402$52,10296 claims
Johnson & JohnsonXarelto$103$48,79154 claims
Astellas Pharma US IncMyrbetriq$177$39,44168 claims
AstraZenecaNexium, Symbicort$14$18,96938 claims
AbbVieLinzess, Synthroid$197$15,56160 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Fort Gaines

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →